UL Launches Medical IoT Battery SOH Transparency Certification Pilot

On May 6, 2026, UL Solutions officially launched a voluntary pilot certification program for State of Health (SOH) transparency of batteries in Medical IoT devices. This initiative directly impacts manufacturers and solution providers supplying battery modules and PCBA for continuous glucose monitors (CGM), portable ultrasound systems, and remote ECG monitoring devices — particularly those engaged in U.S.-bound medical device supply chains.

Event Overview

On May 6, 2026, UL Solutions initiated the Medical IoT Battery ‘State of Health (SOH) Transparency’ voluntary certification pilot. Participating products must output calibrated, real-time SOH parameters—including remaining capacity, cycle count, and internal resistance degradation rate—directly from the device. An open API must be provided to enable remote audit by healthcare institutions. The first phase covers CGM, portable ultrasound, and remote ECG monitoring devices. Three Chinese battery module and PCBA solution providers have been invited to join the pilot.

Industries Affected

Battery Module & PCBA Solution Providers

These suppliers are directly affected because the pilot mandates embedded SOH telemetry and API compliance at the hardware/firmware level. Impact includes revised design requirements for battery management systems (BMS), additional calibration validation steps, and integration efforts with medical device OEMs to support audit-ready data export.

Medical Device OEMs (U.S. and Global)

OEMs integrating third-party battery solutions face new verification obligations before market submission. They must ensure their device firmware supports standardized SOH parameter reporting and secure API access — potentially triggering updates to software architecture, cybersecurity documentation, and regulatory filing packages.

Contract Manufacturers & EMS Providers

EMS partners supporting medical IoT production may need to adapt test protocols to validate SOH output accuracy and API functionality during final assembly or burn-in testing. Traceability of BMS firmware versions and calibration logs becomes a new quality control checkpoint.

What Relevant Enterprises or Practitioners Should Monitor and Do Now

Track official scope expansion and timeline announcements

UL has not yet published formal criteria documents or a public application portal. Current participants are operating under invitation-only terms. Observably, stakeholders should monitor UL’s official communications for release dates of technical specifications, test methods, and eligibility pathways beyond the initial pilot group.

Assess SOH parameter implementation readiness per device class

Analysis shows that CGM and remote ECG devices often use low-power, coin-cell or lithium-polymer batteries with limited telemetry capability. Portable ultrasound units typically employ higher-capacity packs but may lack calibrated internal resistance monitoring. Firms should audit existing BMS capabilities against the three mandated SOH metrics — especially internal resistance degradation rate, which requires temperature-compensated, factory-traceable calibration.

Distinguish between pilot participation and future compliance expectations

The program is currently voluntary and limited to select devices. From industry perspective, this pilot is better understood as a signal of emerging traceability expectations — not an immediate regulatory requirement. However, early adopters may gain advantage in U.S. hospital procurement processes where audit-readiness is increasingly weighted in vendor evaluations.

Prepare cross-functional alignment on firmware, calibration, and API documentation

Current more appropriate preparation includes initiating internal coordination among battery engineering, firmware development, and regulatory affairs teams. Documentation such as calibration certificates, API schema definitions, and data integrity statements should be compiled — even if not yet submitted — to accelerate future engagement with UL or notified bodies.

Editorial Perspective / Industry Observation

This pilot is best interpreted as an early-stage signal of shifting due diligence standards in medical IoT supply chains — specifically around battery lifecycle accountability. Analysis shows UL is aligning with broader healthcare infrastructure trends emphasizing interoperability, remote maintenance, and predictive failure mitigation. However, it remains a pilot: no mandatory adoption date, no harmonized international standard reference, and no linkage yet to FDA 510(k) or ISO 13485 requirements. Observably, its significance lies less in immediate compliance pressure and more in revealing how battery health data may evolve into a non-negotiable layer of clinical device trustworthiness — especially as AI-driven diagnostics rely on stable power behavior.

Conclusion
UL’s SOH transparency pilot marks a procedural inflection point for battery-integrated medical IoT devices, highlighting growing institutional emphasis on verifiable, real-time battery performance data. It does not yet represent a regulatory mandate, nor does it apply broadly across device classes. Rather, it signals an emerging expectation — one that prioritizes transparency over opacity in power system health reporting. Currently, it is more appropriately understood as a forward-looking benchmark for quality and interoperability, rather than a near-term compliance obligation.

Information Sources
Primary source: UL Solutions official announcement (May 6, 2026).
Note: Technical criteria documents, test protocols, and formal application procedures remain pending and are subject to ongoing observation.